Evidence mapPaperPMID 35673477Full record

ArticleJournal of diabetes and metabolic disorders2022

Impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients.

Ibtissem Oueslati, Asma Kardi, Fatma Boukhayatia, Bassem Hammami, Meriem Cheikh, Neila Ben Romdhane, Moncef Feki, Meriem Yazidi, Melika Chihaoui

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ibtissem OueslatiDepartment of Endocrinology, La Rabta University Hospital, Tunis, Tunisia.ORCID 0000-0002-4278-9447
Asma KardiDepartment of Endocrinology, La Rabta University Hospital, Tunis, Tunisia.
Fatma BoukhayatiaDepartment of Endocrinology, La Rabta University Hospital, Tunis, Tunisia.
Bassem HammamiFaculty of Medicine, University of Tunis El Manar, Rue JbelLakhdar, La RabtaJebbari 1007, Tunis, Tunisia.
Meriem CheikhDepartment of Endocrinology, La Rabta University Hospital, Tunis, Tunisia.
Neila Ben RomdhaneFaculty of Medicine, University of Tunis El Manar, Rue JbelLakhdar, La RabtaJebbari 1007, Tunis, Tunisia.
Moncef FekiFaculty of Medicine, University of Tunis El Manar, Rue JbelLakhdar, La RabtaJebbari 1007, Tunis, Tunisia.
Meriem YazidiDepartment of Endocrinology, La Rabta University Hospital, Tunis, Tunisia.
Melika ChihaouiDepartment of Endocrinology, La Rabta University Hospital, Tunis, Tunisia.
Hôpital La Rabta · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The aim of this study was to assess the impact of Ramadan intermittent fasting on metabolic and inflammatory profiles in type 2 diabetic patients (T2D). Methods: It was a prospective study including 55 T2D patients treated with oral hypoglycemic drugs, who intended to observe Ramadan fasting in 2019. All participants underwent a questionnaire, a physical examination, laboratory investigations, and a cardiovascular risk assessment using the Framingham score before Ramadan (T0), immediately after Ramadan (T1), and two months after Ramadan (T2). Results: The mean age of participants was 54.5 ± 10.1 years. The number of fasted days was 29.3 ± 2.3 days. The mean total daily calorie intake decreased significantly by 19% during Ramadan ( Conclusions: Ramadan fasting in T2D patients seems to have a favorable impact on anthropometric parameters and inflammatory profile. However, it may cause a transient worsening of glycemic control.

Indexed as

Anthropometric parametersCardiovascular riskGlycemic controlInflammationIntermittent fastingLipid profileType 2 diabetes

Identifiers

PMID35673477
PMCPMC9167369
OpenAlexW4229049033

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.